In their May 25, 1994, report titled ‘U.S. Chemical and Biological Warfare-Related Dual Use Exports to Iraq and their Possible Impact on the Health Consequences of the Gulf War,’ also known as ‘The Riegle Report,’ Donald W. Riegle, (D-MI) and Alfonse M. D’Amato, former (R-NY) and Chairman and Ranking Member of the Senate Committee on Banking, Housing and Urban Affairs, said: “In October 1992, the Committee on Banking, Housing, and Urban Affairs, which has Senate oversight responsibility for the Export Administration Act (EAA), held an Inquiry into the U.S. export policy to Iraq prior to the [1991] Persian Gulf War. During that hearing it was learned that U.N. Inspectors identified many U.S.-manufactured items exported pursuant to licenses issued by the U.S. Department of Commerce that were used to further Iraq’s chemical and nuclear weapons development and missile delivery system development programs. …we contacted a principal supplier of biological materials to determine what, if any, materials were exported to Iraq which might have contributed to an offensive or defensive biological warfare program. Records available from the supplier for the period from [March] 1985 until the present show that during this time, pathogenic (meaning ‘disease producing’), toxigenic (meaning ‘poisonous’), and other biological research materials were exported to Iraq pursuant to application and licensing by the U.S. Department of Commerce.” [The 15th of the month used for date sorting purposes only.]

 – Donald Wayne Riegle, Jr. and Alfonse M. D’Amato, The Riegle Report, May 25, 1994, Pages 4, 22, 23